143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Psychological well-being at 52 years could impact on cognitive functioning at 69 years

Psychological well-being at 52 years could impact on cognitive functioning at 69 years

by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio

Psychological well-being at 52 years could impact on cognitive functioning at 69 years

by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio
New memory drug moves into Phase 1 clinical study

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with
Blood flow changes in the eyes could influence visual symptoms of migraines

Blood flow changes in the eyes could influence visual symptoms of migraines

byUniversity of California, Los AngelesCredit: Sasha Wolff/WikipediaA recent study found changes in blood flow in the retina could explain why some migraine patients experience visual symptoms.

Blood flow changes in the eyes could influence visual symptoms of migraines

byUniversity of California, Los AngelesCredit: Sasha Wolff/WikipediaA recent study found changes in blood flow in the retina could explain why some migraine patients experience visual symptoms.
Case study reveals potentially lethal side effects of lecanemab for treatment of Alzheimer's disease

Case study reveals potentially lethal side effects of lecanemab for treatment of Alzheimer's disease

by IOS PressThe most striking findings were the mononuclear attack on cerebral amyloid angiopathy (histiocytic vasculitis) with fibrinoid necrosis (left, Aβ immunohistochemistry [4G8]), and focal

Case study reveals potentially lethal side effects of lecanemab for treatment of Alzheimer's disease

by IOS PressThe most striking findings were the mononuclear attack on cerebral amyloid angiopathy (histiocytic vasculitis) with fibrinoid necrosis (left, Aβ immunohistochemistry [4G8]), and focal
Exploring the link between early life stress and maladaptive behavior across species

Exploring the link between early life stress and maladaptive behavior across species

by Ingrid Fadelli , Medical XpressEarly life stressors induce long-term alterations in central mechanisms that drive appropriate social interactions. Being social species, most individuals gain pleasu

Exploring the link between early life stress and maladaptive behavior across species

by Ingrid Fadelli , Medical XpressEarly life stressors induce long-term alterations in central mechanisms that drive appropriate social interactions. Being social species, most individuals gain pleasu
MS treatment that 'resets' immune system may halt disease progression for at least five years

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped
Bio-inspired neuroprosthetics: Sending signals the brain can understand

Bio-inspired neuroprosthetics: Sending signals the brain can understand

by Ori Schipper,ETH ZurichNeuroscience-driven development of a biomimetic neuroprosthetic device. The successful development of a somatosensory neuroprosthesis is based on three main pillars: (1

Bio-inspired neuroprosthetics: Sending signals the brain can understand

by Ori Schipper,ETH ZurichNeuroscience-driven development of a biomimetic neuroprosthetic device. The successful development of a somatosensory neuroprosthesis is based on three main pillars: (1
Challenging assumptions on the economic costs of dementia

Challenging assumptions on the economic costs of dementia

by Trinity College DublinPredicted average health-care cost per patient at diagnosis as well as 10 years before and 6 years after. 95% confidence intervals indicated by the whiskers. Expressed in

Challenging assumptions on the economic costs of dementia

by Trinity College DublinPredicted average health-care cost per patient at diagnosis as well as 10 years before and 6 years after. 95% confidence intervals indicated by the whiskers. Expressed in
Consistently exercising 2–3 times a week over the long term linked to lower current insomnia risk

Consistently exercising 2–3 times a week over the long term linked to lower current insomnia risk

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainConsistently exercising 2–3 times a week over the long term is linked to a lower current risk of insomnia as well as the ability to clo

Consistently exercising 2–3 times a week over the long term linked to lower current insomnia risk

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainConsistently exercising 2–3 times a week over the long term is linked to a lower current risk of insomnia as well as the ability to clo
FDA approves Vyalev for advanced Parkinson's disease

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an
New atlas aims to replace uniform traumatic brain injury treatment with precision medicine

New atlas aims to replace uniform traumatic brain injury treatment with precision medicine

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainResearchers at Phoenix's Barrow Neurological Institute and the University of Pittsburgh have created a vast interactive atlas that

New atlas aims to replace uniform traumatic brain injury treatment with precision medicine

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainResearchers at Phoenix's Barrow Neurological Institute and the University of Pittsburgh have created a vast interactive atlas that